METTL1-mediated m7G tRNA modification promotes lenvatinib resistance in hepatocellular carcinoma. Huang M, Long J, Yao Z, Zhao Y, et al. Cancer Res 2022 Sep 14. pii: 709196. doi: 10.1158/0008-5472.CAN-22-0963.

Read + Share

Amedeo Smart

Independent Medical Education

Huang M, Long J, Yao Z, Zhao Y, et al. METTL1-mediated m7G tRNA modification promotes lenvatinib resistance in hepatocellular carcinoma. Cancer Res 2022 Sep 14. pii: 709196. doi: 10.1158/0008-5472.CAN-22-0963.
PMID: 36102722